Q4 2021 InMed Pharmaceuticals Inc Earnings Call Transcript

Sep 24, 2021 / 03:00PM GMT
Operator

Thank you for standing by, and welcome to the InMed Pharmaceuticals, Inc. fourth-quarter fiscal 2021 financial results and business update. (Operator Instructions) As a reminder, today's program may be recorded.

I would now like to introduce your host for today's program, Bruce Colwill, Chief Financial Officer. Please go ahead, sir.

Colin Clancy - InMed Pharmaceuticals Inc. - IR

Thank you, Jonathan, and good day, ladies and gentlemen. My name is Colin Clancy, InMed's Senior Director of Investor Relations. Welcome to InMed's fourth-quarter and full-year fiscal 2021 financial results and business update conference call. Please note, our speakers are joining us today from remote locations, so we appreciate your patience if we encounter any unexpected technical challenges.

Before we begin, we would like to go over our disclosure statements followed by a review of our recent announcements to acquire BayMedica, together with a progress update on our cannabinoid manufacturing and therapeutic development programs, which will be led by our President

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot